Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
about
Radiotherapy for Colorectal Cancer: Current Standards and Future PerspectivesImaging Procedures for Colorectal CancerNeoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancerImaging Advances in Colorectal CancerOptimizing adjuvant therapy and survivorship care of stage III colon cancer.Factors that influence treatment delay in patients with colorectal cancer.Adjuvant therapy sparing in rectal cancer achieving complete response after chemoradiationWhich is the best postoperative chemotherapy regimen in patients with rectal cancer after neoadjuvant therapy?Locally advanced rectal cancer: the importance of a multidisciplinary approach.Could preoperative short-course radiotherapy be the treatment of choice for localized advanced rectal carcinoma?A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancerIdentification of locally advanced rectal cancer with low risk of local recurrenceCritical evaluation of the scientific content in clinical practice guidelines.Mesenteric ischemia after capecitabine treatment in rectal cancer and resultant short bowel syndrome is not an absolute contraindication for radical oncological treatmentConsensus statement: the 16th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; September 5-6, 2014Optimal delivery of colorectal cancer follow-up care: improving patient outcomes.Low-dose capecitabine adjuvant chemotherapy in elderly stage II/III colorectal cancer patients (LC-ACEC): study protocol for a randomized controlled trial.Apparent Diffusion Coefficient Predicts Pathology Complete Response of Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy.Meta-analysis of oncological outcomes after local excision of pT1-2 rectal cancer requiring adjuvant (chemo)radiotherapy or completion surgery.Estimation of second cancer risk after radiotherapy for rectal cancer: comparison of 3D conformal radiotherapy and volumetric modulated arc therapy using different high dose fractionation schemes.Preoperative conventional chemoradiotherapy versus short-course radiotherapy with delayed surgery for rectal cancer: results of a randomized controlled trial.Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort study.VEGF-C expression is not a prognostic factor in locally advanced colon adenocarcinoma.Tumour regression in the randomized Stockholm III Trial of radiotherapy regimens for rectal cancerPhase 1 dose de-escalation trial of the endogenous folate [6R]-5,10-methylene tetrahydrofolate in combination with fixed-dose pemetrexed as neoadjuvant therapy in patients with resectable rectal cancer.Comparative effectiveness of postoperative chemotherapy among older patients with non-metastatic rectal cancer treated with preoperative chemoradiotherapy.Restaging after neoadjuvant chemoradiation in rectal cancers: is histology the key in patient selection?Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers.Association between obesity and local control of advanced rectal cancer after combined surgery and radiotherapy.Wide Variation in the Use of Radiotherapy in the Management of Surgically Treated Rectal Cancer Across the English National Health Service.Predictive role of microRNA-related genetic polymorphisms in the pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients.TNM-O: ontology support for staging of malignant tumours.Protocol for a multicentre randomised feasibility trial evaluating early Surgery Alone In LOw Rectal cancer (SAILOR).A novel approach to inoperable or recurrent rectal cancer by chemoembolization: A new arrow in our quiver?On a prolonged interval between rectal cancer (chemo)radiotherapy and surgery.Off-label use of anticancer drugs in eastern Switzerland: a population-based prospective cohort study.Optimal Time Intervals between Pre-Operative Radiotherapy or Chemoradiotherapy and Surgery in Rectal Cancer?Evolution of imaging in rectal cancer: multimodality imaging with MDCT, MRI, and PET.Transanal total mesorectal excision for rectal cancer: The journey towards a new technique and its current status.
P2860
Q26738806-09860409-194D-4066-AD65-BE0A08105D5FQ26738809-BF0E0F29-ECA6-4E5E-A05A-31A8D85EC0A3Q27003878-C3B62E8C-CF7F-4363-B208-1112542E467CQ28075896-6FA281AA-329F-497D-BF81-161FE6ABCB7CQ30249616-56ED542F-31A2-473B-A2D7-842996D40EB8Q33829630-72D83D6C-F6F7-476D-B941-704432E04B51Q34499179-7D09FBD6-0A8A-47AC-A657-FFE32327932DQ34630015-E5B9AA33-A3BA-4CD3-A8B0-3D7953EBEB2CQ34696515-18712250-B88D-4EE4-B99A-8C3A660737FCQ34719568-12389647-1C47-4BEF-9C65-B69ED7511871Q34995307-96C7FD87-ED13-4777-A73A-21D13B150316Q35023082-DB72002C-27CD-450B-BCC9-EA6174805B51Q35117790-3733881E-A712-46DC-A15D-D911A1D004C9Q35297106-24FE95BD-F0F5-4020-A7CB-2F0099333AA0Q35445092-C81EA4B0-1F6E-4BC3-ACC6-F647120C09A2Q35654007-E0FCF71E-C33F-4C1B-B4DE-B7FA58426F45Q35733020-3C634215-71D5-41E7-BF3A-2E38D294DE64Q35996086-D902863F-6EC9-47F2-B7E7-FDDAD1EB6BE9Q36052466-88631F26-2A83-47F9-B682-E3C4C025D596Q36189255-986526AE-DB25-4E17-BD89-F71BFFBE0E7AQ36208490-ECC6DE39-9627-4EC5-AC53-9CE6A7F5738AQ36406741-9774F217-21B2-4927-A707-E25047E414C1Q36516066-1DBFC16C-F0AF-4A9B-A682-0F1B29917659Q36554284-0CCCA562-C104-4A83-BE29-9F3255906168Q36621562-201CD652-79C0-4DA4-8DC5-B17F41A95138Q36913615-F7062DA4-909C-42CF-88F7-7782C8070D5EQ36937037-22725E1F-207D-4799-BCBA-4BE1065C2139Q37061363-1C03BD98-0D1B-43FB-B8A5-A0048E34DE4FQ37079037-E37CA321-9880-4131-AF21-FD1A23515C41Q37094342-3BF2AB74-8545-4DA2-8A3A-0C95E2DF2E48Q37190172-E3C71D46-CFEF-4545-9636-B463F72DADC9Q37225193-AB896F3D-701E-452E-861A-4D62D30E83EEQ37414684-85BC14F9-6F5D-4702-9857-45D33C277334Q37454832-56F38112-F82A-42F9-8726-51E6FAEA4FD7Q37564397-0F7400C8-58D6-4EEC-BFD5-26B0CD822EC1Q37715201-37B1C3AA-A4D2-4243-BC1D-0EB171E6E400Q38194452-401A6A97-4176-416A-A58D-FAF3FFA48FCFQ38208009-50D8E98C-D900-4A68-8819-529599A3D32FQ38398872-3934D0DE-5485-4070-8766-9DEF88994D04Q38559105-C73D8244-EDDB-4692-A373-28A42FAE907C
P2860
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
@ast
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
@en
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
@nl
type
label
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
@ast
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
@en
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
@nl
prefLabel
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
@ast
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
@en
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
@nl
P2093
P356
P1433
P1476
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
@en
P2093
A Cervantes
ESMO Guidelines Working Group
P304
P356
10.1093/ANNONC/MDT240
P478
24 Suppl 6
P577
2013-10-01T00:00:00Z